Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Burlison

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|October 17, 1992
Shift in age in chickenpoxD S Sloan, A Burlison
Organic Letters|October 6, 2006
Synthesis and evaluation of coumermycin A1 analogues that inhibit the Hsp90 protein folding machineryJoseph A Burlison, Brian S J Blagg
Placenta|August 27, 2005
PAF levels and PAF-AH activities in placentas from normal and preeclamptic pregnanciesY Gu, S A Burlison, Y Wang
The Journal of Organic Chemistry|April 26, 2003
A general approach to medium ring alkynes by using metathesis of cobalt hexacarbonyl containing dienesDavid G J Young, Joseph A Burlison, Ulf Peters
Current Cancer Drug Targets|November 6, 2007
Hsp90: a novel target for the disruption of multiple signaling cascadesStephanie C Bishop, Joseph A Burlison, Brian S J Blagg
Cancers|May 3, 2014
An Impermeant Ganetespib Analog Inhibits Extracellular Hsp90-Mediated Cancer Cell Migration that Involves Lysyl Oxidase 2-like ProteinJessica McCready, Daniel S Wong, Joseph A Burlison, et al.
Journal of the American Chemical Society|November 30, 2006
Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90Joseph A Burlison, Len Neckers, Andrew B Smith, et al.
The Journal of Organic Chemistry|February 26, 2008
Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell linesJoseph A Burlison, Christopher Avila, George Vielhauer, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 22, 2020
<sup>89</sup>Zr-Labeled Anti-PD-L1 Antibody Fragment for Evaluating <i>In Vivo</i> PD-L1 Levels in Melanoma Mouse ModelCaleb Bridgwater, Anne Geller, Xiaoling Hu, et al.
Molecular Microbiology|July 1, 2014
The Yersinia pestis siderophore, yersiniabactin, and the ZnuABC system both contribute to zinc acquisition and the development of lethal septicaemic plague in miceAlexander G Bobrov, Olga Kirillina, Jacqueline D Fetherston, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|October 17, 1992
Shift in age in chickenpoxD S Sloan, A Burlison
Organic Letters|October 6, 2006
Synthesis and evaluation of coumermycin A1 analogues that inhibit the Hsp90 protein folding machineryJoseph A Burlison, Brian S J Blagg
Placenta|August 27, 2005
PAF levels and PAF-AH activities in placentas from normal and preeclamptic pregnanciesY Gu, S A Burlison, Y Wang
The Journal of Organic Chemistry|April 26, 2003
A general approach to medium ring alkynes by using metathesis of cobalt hexacarbonyl containing dienesDavid G J Young, Joseph A Burlison, Ulf Peters
Current Cancer Drug Targets|November 6, 2007
Hsp90: a novel target for the disruption of multiple signaling cascadesStephanie C Bishop, Joseph A Burlison, Brian S J Blagg
Cancers|May 3, 2014
An Impermeant Ganetespib Analog Inhibits Extracellular Hsp90-Mediated Cancer Cell Migration that Involves Lysyl Oxidase 2-like ProteinJessica McCready, Daniel S Wong, Joseph A Burlison, et al.
Journal of the American Chemical Society|November 30, 2006
Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90Joseph A Burlison, Len Neckers, Andrew B Smith, et al.
The Journal of Organic Chemistry|February 26, 2008
Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell linesJoseph A Burlison, Christopher Avila, George Vielhauer, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 22, 2020
<sup>89</sup>Zr-Labeled Anti-PD-L1 Antibody Fragment for Evaluating <i>In Vivo</i> PD-L1 Levels in Melanoma Mouse ModelCaleb Bridgwater, Anne Geller, Xiaoling Hu, et al.
Molecular Microbiology|July 1, 2014
The Yersinia pestis siderophore, yersiniabactin, and the ZnuABC system both contribute to zinc acquisition and the development of lethal septicaemic plague in miceAlexander G Bobrov, Olga Kirillina, Jacqueline D Fetherston, et al.
Pageof 2